Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Abbott Laboratories

Market Cap 154B 135B 125B 116B 218B 14,578B 220B 1,479B 575B 7,155B 578B 566B 24,878B P/E 2026 *
22.1x
P/E 2027 * 18.9x
Enterprise Value 166B 145B 134B 125B 235B 15,688B 237B 1,591B 618B 7,700B 622B 609B 26,773B EV / Sales 2026 *
3.3x
EV / Sales 2027 * 2.97x
Free-Float
86.73%
Yield 2026 *
2.9%
Yield 2027 * 3.09%
1 day-0.66%
1 week-0.40%
Current month+2.61%
1 month+0.07%
3 months-16.72%
6 months-29.99%
Current year-29.90%
1 week 87.21
Extreme 87.21
91.58
1 month 84.96
Extreme 84.96
92.73
Current year 81.97
Extreme 81.97
129.46
1 year 81.97
Extreme 81.97
139.06
3 years 81.97
Extreme 81.97
141.23
5 years 81.97
Extreme 81.97
142.6
10 years 36.76
Extreme 36.76
142.6
Manager TitleAgeSince
Chief Executive Officer 52 2020-03-30
Director of Finance/CFO 53 2023-08-31
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 2011-12-08
Director/Board Member 67 2011-12-08
Director/Board Member 71 2017-02-15
Date Insider Type Main position Quantity % Market Cap.
Apr. 27Other

Head of Human Resources

5,314 0.0003%
Apr. 23Free

Director

2,286 0.0001%
Apr. 23Other

Director

131,451 0.0076%
Change 5-day change 1-year change 3-year change Capi.($)
-0.66%-0.40%-33.96%-17.34% 154B
-0.09%-1.16%-8.19%-10.25% 102B
-0.99%+2.10%+59.76%+56.65% 56.51B
-0.20%-3.69%-7.62%+45.98% 52.89B
-2.27%-3.78%-16.45%-45.31% 39.67B
-3.42%-5.19% - - 30.39B
-4.69%-8.36%-13.66%-45.98% 27.96B
+0.54%+0.27%+52.77%-10.62% 23.17B
+0.90%+2.05%-14.45%-4.79% 20.35B
-1.09%-3.45%-14.97%-5.50% 19.75B
Average -1.20%-1.39%+0.36%-4.13% 52.62B
Weighted average by Cap. -0.94%-1.28%-7.04%-3.25%

Financials

2026 *2027 *
Net sales 50.29B 44B 40.66B 37.96B 71.19B 4,761B 71.84B 483B 188B 2,337B 189B 185B 8,124B 54.79B 47.94B 44.3B 41.36B 77.57B 5,187B 78.27B 526B 204B 2,546B 206B 201B 8,852B
Net income 7.02B 6.14B 5.67B 5.3B 9.94B 664B 10.03B 67.4B 26.19B 326B 26.35B 25.78B 1,134B 8.39B 7.34B 6.79B 6.33B 11.88B 794B 11.99B 80.59B 31.32B 390B 31.51B 30.82B 1,356B
Net Debt 11.73B 10.26B 9.48B 8.85B 16.6B 1,110B 16.75B 113B 43.76B 545B 44.02B 43.07B 1,894B 8.88B 7.77B 7.18B 6.7B 12.58B 841B 12.69B 85.3B 33.15B 413B 33.35B 32.63B 1,435B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change Volume
26-06-22 87.83 $ -0.66% 10,746,740
26-06-18 88.41 $ -0.10% 41,964,841
26-06-17 88.50 $ -2.34% 13,052,998
26-06-16 90.62 $ +2.20% 12,740,746
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
87.83USD
Average target price
116.54USD
Spread / Average Target
+32.69%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!